DCAT Value Chain Insights Podcast - Older Episodes

Podcast Archive

Listen to specially selected articles from our website that feature in-depth analysis on the issues impacting the business of pharmaceutical development and manufacturing.

  applepodcastbadge copy   google podcasts badge8x     spotify badge

Drug Supply Chains and US-Based Manufacturing
March 23, 2020

What does the global nature of the pharmaceutical supply chain mean for US policy? In this podcast, we feature an article that looks at proposals from members of Congress and the federal government to incentivize domestic drug manufacturing in the US. 

This podcast is sponsored by: CordenPharma   

Blockbuster Watch for 2020: New Market Entrants
March 2, 2020

What are the new blockbuster medicines to watch? In this podcast we feature an article that examines the eleven medicines projected to enter the market in 2020 and achieve blockbuster status by 2024, according to a recent analysis by Clarivate Analytics’ Cortellis Forecast Team.

This podcast is sponsored by: CordenPharma   

Orphan Drugs: Bearing Revenue Gains or Not? 
February 25, 2020

Over the past several years, orphan drugs have accounted for more than 40% of new drug approvals by the FDA.  In this podcast, we showcase an article that explores whether they are producing the revenue gains pharma companies are seeking or if they are too niche? 

This podcast is sponsored by: CordenPharma   

Emerging Biopharma Companies: Tracking Their Contribution to Innovation
February 14, 2020

To what extent do emerging pharma companies contribute to the pharmaceutical industry’s pipeline and new product growth? In this podcast, we showcase an article examining a recent report by IQVIA that analyzes emerging bio pharma companies’ contribution to innovation.

This podcast is sponsored by: CordenPharma   

20-20 Insights and Outlook for the CDMO Market
January 15, 2020

The conditions are favorable for another strong year of performance for CDMOs. In this podcast, we showcase an article written by Jim Miller, Consultant and Content Advisor at DCAT, that examines industry fundamentals and an outlook for pharma outsourcing in 2020.

This podcast is sponsored by: CordenPharma